JPRN-UMIN000004656已完成未知
Serum PAI-1 levels in type 2 diabetic patients on sitagliptin treatment - PAI-1 in T2DM on sitagliptin
Yokohama City University, Graduate School of Medicine0 个研究点目标入组 80 人开始时间: 2010年12月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
We investigated a possible association between serum plasminogen activator inhibitor-1 (PAI-1) levels and renal dysfunction in 124 type 2 diabetes patients. Multiple linear regression analyses indicated that the PAI-1 levels were significantly inversely correlated with estimated glomerular filtration rate (eGFR) independent of albuminuria, BMI, LDL-C, and triglyceride.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1> patient treated with insulin injection 2> patient treated with GLP-1 receptor agonists
研究者
相似试验
已完成
2 期
Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic ShockSevere SepsisSeptic ShockNCT00159952Policlinico Hospital90
招募中
不适用
The study for association between circulating angiopoetin like protein 2 (ANGPTL2) and various markers related to diabetes in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000025767Dokkyo Medical University Koshigaya Hospital70
已完成
不适用
Novel Biomarker for Development of T2DDiabetes Type IINCT02326129Duke University202
尚未招募
不适用
Apelin as a Marker of Early Complications in Type 1 Diabetes MellitusDiabetes Mellitus, Type 1NCT05738577Assiut University90
已完成
不适用
Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress PreventionType 1 DiabetesNCT00934336Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète50